Table 2 Risk factors for the development of early post-transplant infection in younger recipients

Sex, female

1.276 (1.074–1.515)

1.323 (1.103–1.587)

BMI (kg/m²)

1.017 (0.993–1.041)

 Diabetes mellitus

1

 Hypertension

1.007 (0.756–1.341)

 Glomerulonephritis

1.007 (0.796–1.275)

 ADPKD

1.100 (0.712–1.700)

 Others

1.209 (0.761–1.921)

 Unknown

0.913 (0.691–1.205)

Duration of dialysis (month)

1.002 (1.001–1.003)

1.000 (0.999–1.002)

Diabetes mellitus

1.015 (0.834–1.237)

Hypertension

1.021 (0.779–1.336)

Cardiovascular disease

1.520 (1.167–1.980)

1.454 (1.108–1.906)

Creatinine, baseline (mg/dL)

1.004 (0.979–1.030)

Creatinine, discharge (mg/dL)

1.015 (0.916–1.125)

Re-transplantation

1.065 (0.782–1.450)

Deceased donor

1.553 (1.306–1.846)

1.409 (1.120–1.772)

Donor age (year)

1.010 (1.003–1.017)

1.008 (1.001–1.015)

Donor sex, female

1.346 (1.129–1.604)

1.192 (0.992–1.433)

Desensitization

1.015 (0.829–1.243)

ABO incompatibility

0.757 (0.586–0.979)

0.934 (0.708–1.230)

Presence of DSA

1.536 (1.128–2.092)

1.427 (1.016–2.006)

Length of hospitalization after KT (day)

1.015 (1.011–1.020)

1.011 (1.006–1.017)

No use

1

1

 Basiliximab

2.226 (0.831–5.959)

2.511 (0.479–8.252)

 ATG

2.760 (1.016–7.493)

2.589 (0.952–7.042)

 Basiliximab + ATG

2.894 (0.953–8.793)

2.337 (0.767–7.118)

 No use

1

 Tacrolimus

1.345 (0.503–3.597)

 Cyclosporine

1.146 (0.377–3.481)

Steroid

1.477 (0.735–2.970)

Acute rejection

2.993 (2.499–3.585)

2.637 (2.455–3.426)